Else Balke – September 2018

Gene polymorphisms and clinical outcome at various stages of (pre)type 1 diabetes

Olivier Costa – Februari 2017

Development of advanced immunoassays for subpicomolar detection of plasma GAD65 as biomarker of beta cell destruction

Annelien Van Dalem - Maart 2017

Minimally-invasive measurements of beta cell function in (pre)type 1 diabetes

Simke Demeester - Juni 2016

Biomarkers to predict functional outcome to beta cell therapy trials in type 1 diabetes

Eric Balti Vounsia - Juni 2015

Biological prediction of rapid progression to type 1 diabetes: Preparing for immune intervention trials in the preclinical disease phase

Milca Asanghanwa – juni 2014

Biomarkers in diabetes patients under age 40: comparison between Cameroon and Belgium

Eric Mbunwe – oktober 2013

Contribution of screening for HLA class I alleles to prediction of type 1 diabetes in risk groups

Farah van Genderen – juni 2013

Multiplex and species-specific immunoassays for measuring beta cell peptides in experimental and clinical studies

Ilse Vermeulen - Juni 2012

Refining the diagnostic armamentarium for classification and prediction of type 1 diabetes

Robert Hilbrands - Mei 2012

Immune monitoring in type 1 diabetic recipients of defined beta cell grafts: contribution to assess clinical outcome

Evy Vandemeulebroucke - Februari 2011

Preservation of functional beta cell mass, assessed by hyperglycemic clamp, in human type 1 diabetes

Folefac Aminkeng – september 2010

Refining the immunogenetic risk of type 1 diabetes in the Belgian population

Jan Van Autreve - Juli 2008

Study of genetic markers for type 1 diabetes within and outside the HLA region in the Belgian population

Inge Truyen - December 2007

Identification of prediabetes in first degree relatives of type 1 diabetic probands

Katelijn Decochez - Mei 2005

Prediction of beta cell loss by islet autoantibodies: implications for prevention trials in humans

Ilse Weets - Februari 2004

Ethiological and phenotypical heterogeneity of diabetes presenting before age 40 according to demographic and biological parameters: variable contribution of genetic and external factors

Christophe De Block - Mei 2002

Clinical significance of parietal cell antibodies with regard to manifestation of autoimmune gastropathy in type 1 diabetic patients

Bart Van der Auwera - Maart 1999

HLA and non-HLA genes in insulin-dependent diabetes mellitus. Contribution to a refined immunogenetic risk assessment.

Christina Vandewalle - Maart 1998

Epidemiology, clinical aspects and early biological markers of new-onset IDDM patients (0-39 years): the importance of diabetes registries for preventive health care strategies.